Cellectar Biosciences, Inc. Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Cellectar Biosciences, Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • Cellectar Biosciences, Inc. Return On Equity for the quarter ending September 30, 2024 was -805 %, a 214% decline year-over-year.
  • Cellectar Biosciences, Inc. annual Return On Equity for 2023 was 341 %.
  • Cellectar Biosciences, Inc. annual Return On Equity for 2022 was -212 %, a 255% decline from 2021.
  • Cellectar Biosciences, Inc. annual Return On Equity for 2021 was -59.8 %, a 4.7% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 341 +553 Jan 1, 2023 Dec 31, 2023
2022 -212 -152 -255% Jan 1, 2022 Dec 31, 2022
2021 -59.8 +2.95 +4.7% Jan 1, 2021 Dec 31, 2021
2020 -62.7 +56.9 +47.6% Jan 1, 2020 Dec 31, 2020
2019 -120 +5.57 +4.45% Jan 1, 2019 Dec 31, 2019
2018 -125 +1.09 +0.86% Jan 1, 2018 Dec 31, 2018
2017 -126 -52.8 -72% Jan 1, 2017 Dec 31, 2017
2016 -73.4 +163 +69% Jan 1, 2016 Dec 31, 2016
2015 -237 +5.49 +2.27% Jan 1, 2015 Dec 31, 2015
2014 -242 -11.4 -4.95% Jan 1, 2014 Dec 31, 2014
2013 -231 -137 -145% Jan 1, 2013 Dec 31, 2013
2012 -94 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.